School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
J Ethnopharmacol. 2024 Feb 10;320:117401. doi: 10.1016/j.jep.2023.117401. Epub 2023 Nov 13.
Astragalus polysaccharide (APS) extracted from Astragalus membranaceus (Fisch.) Bunge was proven to be effective in preventing high-fat diet (HFD) induced nonalcoholic fatty liver disease (NAFLD). However, the exact mechanisms were not completely elucidated.
The aim was to reveal the mechanisms of APS on preventing NAFLD from the aspects of regulating bile acids (BAs) homeostasis.
Serum and liver BAs in HFD fed mice with or without APS intervention were quantified with an ultra-performance liquid chromatography coupled to tandem mass spectrometry (UPLC-MS/MS) system. The effect of APS on hepatic proteins involved in BAs synthesis were analyzed with Western blot. Finally, the effect of identified taurohyodeoxycholic acid (THDCA) that was significantly increased by APS on hepatic triglyceride (TG) accumulation was explored in vivo and in vitro.
APS regulated serum and liver BA profiles in HFD fed mice, especially increased serum THDCA. The levels of hepatic cholesterol 7a-hydroxylase (CYP7A1) and sterol 12a-hydroxylase (CYP8B1) which catalyzed the classical BAs synthesis pathway were significantly decreased by APS, while oxysterol 7a-hydroxylase (CYP7B1) which catalyzed the alternative BAs synthesis pathway was significantly increased by APS. THDCA reduced HFD-induced hepatic lipid accumulation and improved glucose homeostasis in mice, and decreased TG level in palmitic acid/oleic acid treated alpha mouse liver 12 (AML-12) cells. THDCA significantly downregulated the protein level of cluster of differentiation 36 (CD36) involved in fatty acid transport into the liver. Importantly, THDCA showed similar effect with APS in upregulating hepatic CYP7B1 and downregulating CYP7A1.
This study revealed the protective effect of APS on NAFLD was associated with the regulation on BA profiles, and proved the potential anti-NAFLD effect of THDCA, highlighting the involvement of BA metabolism in efficacy of herb-derived polysaccharides on metabolism.
从黄芪(膜荚黄芪)中提取的黄芪多糖(APS)已被证明可有效预防高脂肪饮食(HFD)诱导的非酒精性脂肪肝疾病(NAFLD)。然而,确切的机制尚未完全阐明。
本研究旨在从调节胆汁酸(BAs)稳态的角度揭示 APS 预防 NAFLD 的机制。
采用超高效液相色谱-串联质谱(UPLC-MS/MS)系统定量检测 HFD 喂养的小鼠血清和肝脏 BAs,以及 APS 干预后的变化。Western blot 分析 APS 对参与 BAs 合成的肝蛋白的影响。最后,在体内和体外研究 APS 显著增加的牛磺去氧胆酸(THDCA)对肝甘油三酯(TG)积累的影响。
APS 调节了 HFD 喂养小鼠的血清和肝脏 BA 谱,特别是增加了血清中的 THDCA。APS 显著降低了经典 BAs 合成途径中的肝胆固醇 7a-羟化酶(CYP7A1)和甾醇 12a-羟化酶(CYP8B1)水平,而 APS 显著增加了替代 BAs 合成途径中的氧化固醇 7a-羟化酶(CYP7B1)。THDCA 可减少 HFD 诱导的肝脂质积累,改善小鼠葡萄糖稳态,并降低棕榈酸/油酸处理的 alpha 鼠肝 12(AML-12)细胞中的 TG 水平。THDCA 显著下调了参与脂肪酸向肝脏转运的分化簇 36(CD36)蛋白水平。重要的是,THDCA 表现出与 APS 相似的上调肝 CYP7B1 和下调 CYP7A1 的作用。
本研究揭示了 APS 对 NAFLD 的保护作用与 BA 谱的调节有关,并证明了 THDCA 的潜在抗 NAFLD 作用,突出了 BA 代谢在草药衍生多糖代谢疗效中的作用。